Cargando…

Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade

BACKGROUND: Changes in the levels of C-reactive protein (CRP), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6) observed during periodontal disease were linked with vascular manifestations. Recent studies showed that the beta-blocker propranolol reduces the pathological parameters associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Wellington Francisco, Miguel, Camila Botelho, Lazo-Chica, Javier Emilio, Trindade da Silva, Carlos Antônio, Vieira, Carlos Ueira, Clemente-Napimoga, Juliana Trindade, Freire Oliveira, Carlo José, Napimoga, Marcelo Henrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906902/
https://www.ncbi.nlm.nih.gov/pubmed/31849395
http://dx.doi.org/10.4103/jisp.jisp_77_19
_version_ 1783478445861240832
author Rodrigues, Wellington Francisco
Miguel, Camila Botelho
Lazo-Chica, Javier Emilio
Trindade da Silva, Carlos Antônio
Vieira, Carlos Ueira
Clemente-Napimoga, Juliana Trindade
Freire Oliveira, Carlo José
Napimoga, Marcelo Henrique
author_facet Rodrigues, Wellington Francisco
Miguel, Camila Botelho
Lazo-Chica, Javier Emilio
Trindade da Silva, Carlos Antônio
Vieira, Carlos Ueira
Clemente-Napimoga, Juliana Trindade
Freire Oliveira, Carlo José
Napimoga, Marcelo Henrique
author_sort Rodrigues, Wellington Francisco
collection PubMed
description BACKGROUND: Changes in the levels of C-reactive protein (CRP), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6) observed during periodontal disease were linked with vascular manifestations. Recent studies showed that the beta-blocker propranolol reduces the pathological parameters associated with certain molecules at sites of bone injury. Hence, in this study, we evaluated the activity of propranolol on hematological parameters and systemic concentrations of inflammatory proteins in a model of experimental periodontitis. MATERIALS AND METHODS: Periodontal disease was induced in rats. After euthanasia, the number of inflammatory cells in each rat was quantified using histopathological assays. In addition, hematological parameters were quantitated using automated analysers, cytokine levels were determined using an enzyme-linked immunosorbent assay, and CRP levels were determined using a high-sensitivity immunoturbidimetric assay. RESULTS: Low doses of propranolol suppressed the systemic production of CRP, TNF-α, and IL-6; however, the hematological parameters were not affected. CONCLUSIONS: β-adrenergic activation indirectly contributes to the pattern of systemic inflammatory molecules observed in periodontal disease. These molecules may initiate cardiovascular diseases as a consequence of periodontitis.
format Online
Article
Text
id pubmed-6906902
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-69069022019-12-17 Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade Rodrigues, Wellington Francisco Miguel, Camila Botelho Lazo-Chica, Javier Emilio Trindade da Silva, Carlos Antônio Vieira, Carlos Ueira Clemente-Napimoga, Juliana Trindade Freire Oliveira, Carlo José Napimoga, Marcelo Henrique J Indian Soc Periodontol Original Article BACKGROUND: Changes in the levels of C-reactive protein (CRP), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6) observed during periodontal disease were linked with vascular manifestations. Recent studies showed that the beta-blocker propranolol reduces the pathological parameters associated with certain molecules at sites of bone injury. Hence, in this study, we evaluated the activity of propranolol on hematological parameters and systemic concentrations of inflammatory proteins in a model of experimental periodontitis. MATERIALS AND METHODS: Periodontal disease was induced in rats. After euthanasia, the number of inflammatory cells in each rat was quantified using histopathological assays. In addition, hematological parameters were quantitated using automated analysers, cytokine levels were determined using an enzyme-linked immunosorbent assay, and CRP levels were determined using a high-sensitivity immunoturbidimetric assay. RESULTS: Low doses of propranolol suppressed the systemic production of CRP, TNF-α, and IL-6; however, the hematological parameters were not affected. CONCLUSIONS: β-adrenergic activation indirectly contributes to the pattern of systemic inflammatory molecules observed in periodontal disease. These molecules may initiate cardiovascular diseases as a consequence of periodontitis. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6906902/ /pubmed/31849395 http://dx.doi.org/10.4103/jisp.jisp_77_19 Text en Copyright: © 2019 Indian Society of Periodontology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Rodrigues, Wellington Francisco
Miguel, Camila Botelho
Lazo-Chica, Javier Emilio
Trindade da Silva, Carlos Antônio
Vieira, Carlos Ueira
Clemente-Napimoga, Juliana Trindade
Freire Oliveira, Carlo José
Napimoga, Marcelo Henrique
Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade
title Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade
title_full Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade
title_fullStr Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade
title_full_unstemmed Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade
title_short Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade
title_sort interleukin-6, tumor necrosis factor-α, c-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906902/
https://www.ncbi.nlm.nih.gov/pubmed/31849395
http://dx.doi.org/10.4103/jisp.jisp_77_19
work_keys_str_mv AT rodrigueswellingtonfrancisco interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade
AT miguelcamilabotelho interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade
AT lazochicajavieremilio interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade
AT trindadedasilvacarlosantonio interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade
AT vieiracarlosueira interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade
AT clementenapimogajulianatrindade interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade
AT freireoliveiracarlojose interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade
AT napimogamarcelohenrique interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade